Filing exhibits
- 8-K Current report
- 2.1 Agreement and Plan of Merger, Dated March 6, 2024, by and Among Biomx Inc., BTX Merger Sub I, Inc., BTX Merger Sub II, LLC and Adaptive Phage Therapeutics, Inc
- 3.1 Form of Certificate of Designation of Series X Preferred Stock
- 4.1 Form of Merger Warrant
- 4.2 Form of Private Placement Warrant
- 4.3 Form of Placement Agent Warrant
- 10.1 Securities Purchase Agreement, Dated As of March 6, 2024, by and Among Biomx Inc. and Each Purchaser Identified on Annex a Thereto
- 10.2 Form of Registration Rights Agreement, Dated As of March 6, 2024, by and Among the Company and Certain Purchasers
- 99.1 Form of Support Agreement
- 99.2 Form of Lock-up Agreement
- 99.3 Investor Presentation, Dated March 6, 2024
- Download Excel data file
- View Excel data file
Table of Contents